Last updated on January 2020

A Study Investigating the Safety Tolerability and Efficacy of ASP7517 in Subjects With Relapsed/Refractory Acute Myeloid Leukemia (AML) and Relapsed/Refractory Higher Risk Myelodysplastic Syndrome (MDS)


Find a site near you

Start Over

Site JP81001

Shinagawa, Japan
3.41miles
  Connect »